These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

532 related items for PubMed ID: 19380458

  • 1. 17Beta-estradiol inhibits 11beta-hydroxysteroid dehydrogenase type 1 activity in rodent adipocytes.
    Tagawa N, Yuda R, Kubota S, Wakabayashi M, Yamaguchi Y, Kiyonaga D, Mori N, Minamitani E, Masuzaki H, Kobayashi Y.
    J Endocrinol; 2009 Jul; 202(1):131-9. PubMed ID: 19380458
    [Abstract] [Full Text] [Related]

  • 2. Alternative mechanism for anti-obesity effect of dehydroepiandrosterone: possible contribution of 11β-hydroxysteroid dehydrogenase type 1 inhibition in rodent adipose tissue.
    Tagawa N, Minamitani E, Yamaguchi Y, Kobayashi Y.
    Steroids; 2011 Dec 20; 76(14):1546-53. PubMed ID: 21945397
    [Abstract] [Full Text] [Related]

  • 3. Resveratrol inhibits 11β-hydroxysteroid dehydrogenase type 1 activity in rat adipose microsomes.
    Tagawa N, Kubota S, Kato I, Kobayashi Y.
    J Endocrinol; 2013 Sep 20; 218(3):311-20. PubMed ID: 23814014
    [Abstract] [Full Text] [Related]

  • 4. Bezafibrate regulates the expression and enzyme activity of 11beta-hydroxysteroid dehydrogenase type 1 in murine adipose tissue and 3T3-L1 adipocytes.
    Nakano S, Inada Y, Masuzaki H, Tanaka T, Yasue S, Ishii T, Arai N, Ebihara K, Hosoda K, Maruyama K, Yamazaki Y, Shibata N, Nakao K.
    Am J Physiol Endocrinol Metab; 2007 Apr 20; 292(4):E1213-22. PubMed ID: 17190905
    [Abstract] [Full Text] [Related]

  • 5. Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor, 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2H-1,2-benzothiazine-2-yl-1-phenylethanone (KR-66344).
    Park JS, Rhee SD, Kang NS, Jung WH, Kim HY, Kim JH, Kang SK, Cheon HG, Ahn JH, Kim KY.
    Biochem Pharmacol; 2011 Apr 15; 81(8):1028-35. PubMed ID: 21315688
    [Abstract] [Full Text] [Related]

  • 6. Hexose-6-phosphate dehydrogenase modulates the effect of inhibitors and alternative substrates of 11beta-hydroxysteroid dehydrogenase 1.
    Balázs Z, Nashev LG, Chandsawangbhuwana C, Baker ME, Odermatt A.
    Mol Cell Endocrinol; 2009 Mar 25; 301(1-2):117-22. PubMed ID: 19010388
    [Abstract] [Full Text] [Related]

  • 7. Suppression of 11beta-hydroxysteroid dehydrogenase type 1 with RNA interference substantially attenuates 3T3-L1 adipogenesis.
    Liu Y, Park F, Pietrusz JL, Jia G, Singh RJ, Netzel BC, Liang M.
    Physiol Genomics; 2008 Feb 19; 32(3):343-51. PubMed ID: 18073273
    [Abstract] [Full Text] [Related]

  • 8. Dehydroepiandrosterone inhibits the amplification of glucocorticoid action in adipose tissue.
    Apostolova G, Schweizer RA, Balazs Z, Kostadinova RM, Odermatt A.
    Am J Physiol Endocrinol Metab; 2005 May 19; 288(5):E957-64. PubMed ID: 15613680
    [Abstract] [Full Text] [Related]

  • 9. 11beta-Hydroxysteroid dehydrogenase 1 reductase activity is dependent on a high ratio of NADPH/NADP(+) and is stimulated by extracellular glucose.
    Dzyakanchuk AA, Balázs Z, Nashev LG, Amrein KE, Odermatt A.
    Mol Cell Endocrinol; 2009 Mar 25; 301(1-2):137-41. PubMed ID: 18778749
    [Abstract] [Full Text] [Related]

  • 10. Genistein inhibits glucocorticoid amplification in adipose tissue by suppression of 11β-hydroxysteroid dehydrogenase type 1.
    Tagawa N, Kubota S, Kobayashi Y, Kato I.
    Steroids; 2015 Jan 25; 93():77-86. PubMed ID: 25447798
    [Abstract] [Full Text] [Related]

  • 11. Anti-diabetic and anti-adipogenic effects of a novel selective 11β-hydroxysteroid dehydrogenase type 1 inhibitor in the diet-induced obese mice.
    Park JS, Rhee SD, Jung WH, Kang NS, Kim HY, Kang SK, Ahn JH, Kim KY.
    Eur J Pharmacol; 2012 Sep 15; 691(1-3):19-27. PubMed ID: 22760069
    [Abstract] [Full Text] [Related]

  • 12. The discovery of new 11beta-hydroxysteroid dehydrogenase type 1 inhibitors by common feature pharmacophore modeling and virtual screening.
    Schuster D, Maurer EM, Laggner C, Nashev LG, Wilckens T, Langer T, Odermatt A.
    J Med Chem; 2006 Jun 15; 49(12):3454-66. PubMed ID: 16759088
    [Abstract] [Full Text] [Related]

  • 13. Active site variability of type 1 11beta-hydroxysteroid dehydrogenase revealed by selective inhibitors and cross-species comparisons.
    Hult M, Shafqat N, Elleby B, Mitschke D, Svensson S, Forsgren M, Barf T, Vallgårda J, Abrahmsen L, Oppermann U.
    Mol Cell Endocrinol; 2006 Mar 27; 248(1-2):26-33. PubMed ID: 16431016
    [Abstract] [Full Text] [Related]

  • 14. Upregulation of adipose 11-beta-hydroxysteroid dehydrogenase type 1 expression in ovariectomized rats is due to obesity rather than lack of estrogen.
    Paulsen SK, Nielsen MP, Richelsen B, Bruun JM, Flyvbjerg A, Pedersen SB.
    Obesity (Silver Spring); 2008 Apr 27; 16(4):731-5. PubMed ID: 18379559
    [Abstract] [Full Text] [Related]

  • 15. Effects of bile acids on rat hepatic microsomal type I 11beta-hydroxysteroid dehydrogenase.
    Maeda Y, Naganuma S, Niina I, Shinohara A, Koshimoto C, Kondo K, Chijiiwa K.
    Steroids; 2010 Feb 27; 75(2):164-8. PubMed ID: 19948178
    [Abstract] [Full Text] [Related]

  • 16. Comparative enzymology of 11beta-hydroxysteroid dehydrogenase type 1 from six species.
    Arampatzis S, Kadereit B, Schuster D, Balazs Z, Schweizer RA, Frey FJ, Langer T, Odermatt A.
    J Mol Endocrinol; 2005 Aug 27; 35(1):89-101. PubMed ID: 16087724
    [Abstract] [Full Text] [Related]

  • 17. Role of 11-beta-hydroxysteroid dehydrogenase type 1 in differentiation of 3T3-L1 cells and in rats with diet-induced obesity.
    Liu Y, Sun WL, Sun Y, Hu G, Ding GX.
    Acta Pharmacol Sin; 2006 May 27; 27(5):588-96. PubMed ID: 16626514
    [Abstract] [Full Text] [Related]

  • 18. Inhibition of 11beta-hydroxysteroid dehydrogenase type 1 as a promising therapeutic target.
    Wamil M, Seckl JR.
    Drug Discov Today; 2007 Jul 27; 12(13-14):504-20. PubMed ID: 17631244
    [Abstract] [Full Text] [Related]

  • 19. Discovery and structure-activity relationships of pentanedioic acid diamides as potent inhibitors of 11beta-hydroxysteroid dehydrogenase type I.
    Roche D, Carniato D, Leriche C, Lepifre F, Christmann-Franck S, Graedler U, Charon C, Bozec S, Doare L, Schmidlin F, Lecomte M, Valeur E.
    Bioorg Med Chem Lett; 2009 May 15; 19(10):2674-8. PubMed ID: 19395260
    [Abstract] [Full Text] [Related]

  • 20. Benzofuran derivatives inhibit 11β-hydroxysteroid dehydrogenase type 1 activity in rat adipose tissue.
    Kiyonaga D, Tagawa N, Yamaguchi Y, Wakabayashi M, Kogure T, Ueda M, Miyata O, Kobayashi Y.
    Biol Pharm Bull; 2012 May 15; 35(8):1275-80. PubMed ID: 22863925
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 27.